Multiple Breast Cancer Risk Factors Do Not Improve Patient Acceptance of Chemoprevention.

被引：0
|
作者：
Lo, S. S. [1 ]
Henry, E. [1 ]
Rychlik, K. [1 ]
Mumby, P. [1 ]
Bowling, L. [1 ]
Robinson, P. [1 ]
Albain, K. S. [1 ]
机构：
[1] Loyola Univ Chicago, Maywood, IL USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：551S / 551S
页数：1
相关论文
共 50 条
  • [1] Knowledge and interest in breast cancer chemoprevention.
    Kinsinger, LS
    Harris, RP
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 : 144 - 144
  • [2] Correlation between risk benefit index and uptake of breast cancer chemoprevention.
    Sivasubramanian, Parijatham S.
    Crew, Katherine D.
    Kalinsky, Kevin
    Hershman, Dawn L.
    Maurer, Matthew A.
    Greenlee, Heather
    Reimers, Laura L.
    Terry, Mary Beth
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention.
    Boyd N.F.
    Martin L.J.
    Stone J.
    Greenberg C.
    Minkin S.
    Yaffe M.J.
    [J]. Current Oncology Reports, 2001, 3 (4) : 314 - 321
  • [4] Acceptance of Chemoprevention by Women at High Risk for Breast Cancer
    Lane, Karen
    Hyunh, Kelly
    Smith, Edie
    Hsiang, David
    Butler, John
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (02) : S180 - S180
  • [5] Breast cancer chemoprevention. Rational, trials results and future
    Cutuli, B.
    Lesur, A.
    Namer, M.
    Kerbrat, P.
    [J]. BULLETIN DU CANCER, 2009, 96 (05) : 519 - 530
  • [6] Referral to a High-Risk Breast Clinic Can Improve Patient Acceptance and Compliance With Chemoprevention Therapies
    Gates, Elise
    Lee, Connie
    Edmiston, Kathryn
    Larkin, Anne
    Quinlan, Robert
    Sharron, Amy
    Ward, B. Marie
    O'Connor, Ashling
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : 47 - 47
  • [7] Stage of preneoplastic breast cancer progression impacts the efficacy of chemoprevention.
    Bhardwaj, Anjana
    Singh, Harpreet
    Bedrosian, Isabelle
    [J]. MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 79 - 79
  • [8] Inhibition of fatty acid synthase (FAS) for breast cancer chemoprevention.
    Alli, PM
    Pinn, M
    Jaffe, E
    Kuhajda, F
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (11) : 1344S - 1344S
  • [9] Acceptance and adherence to chemoprevention among women at increased risk of breast cancer
    Roetzheim, Richard G.
    Lee, Ji-Hyun
    Fulp, William
    Gomez, Elizabeth Matos
    Clayton, Elissa
    Tollin, Sharon
    Khakpour, Nazanin
    Laronga, Christine
    Lee, Marie Catherine
    Kiluk, John V.
    [J]. BREAST, 2015, 24 (01): : 51 - 56
  • [10] IGFBP6: an RXR-induced mediator of breast cancer chemoprevention.
    Uray, IP
    Seo, HS
    Kim, H
    William, L
    Johnson, K
    Brown, P
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S158 - S158
12345